
Loading, please wait...

Loading, please wait...

Maintaining genomic stability is vital for reproductive success. Recent studies reveal that DNA damage repair oogenesis depends heavily on Replication Protein A1 (RPA1). This protein acts as the largest subunit of the RPA complex. When researchers inactivate RPA1, the entire complex disassembles. Consequently, oocytes accumulate severe DNA damage that prevents healthy development.
To understand this process, scientists used germline-specific Cre drivers to deplete RPA1 in mammalian models. This loss triggers several canonical pathways. For instance, sensors like ATM and ATR become highly active. Furthermore, p53 and DNA-PK signal a robust response to the accumulated damage. Without functional RPA1, the oocyte cannot mend its genetic material. Therefore, the cell enters a state of genomic instability that halts normal maturation.
Beyond initial repairs, RPA deficiency impacts chromosomal behavior. It leads to significant misalignment during metaphase I and metaphase II. Moreover, altered transcript levels affect the cytoskeleton organization. This disruption impairs folliculogenesis and reduces the total oocyte pool. Ultimately, the lack of RPA1 causes female infertility. This discovery highlights a previously unrecognized role for RPA in mammalian reproductive health and may offer new insights into clinical cases of idiopathic infertility.
RPA1 is the primary subunit of the RPA complex, which binds to single-stranded DNA. It is essential for repairing DNA breaks that occur during oogenesis. Without it, oocytes cannot maintain their genetic integrity.
RPA1 deficiency leads to the disassembly of the RPA complex. This results in severe DNA damage, activation of cellular stress pathways like p53, and chromosome misalignment, which eventually causes infertility.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Miao X et al. Replication Protein A1 is essential for DNA damage repair during mammalian oogenesis†. Biol Reprod. 2026 Feb 27. doi: undefined. PMID: 41757504.
Zhang L et al. Molecular regulation of DNA damage and repair in female infertility: a systematic review. J Assist Reprod Genet. 2024 Aug 14. doi: 10.1007/s10815-024-03214-7.
Ruggeri E et al. Identification and Preliminary Analysis of Granulosa Cell Biomarkers to Predict Oocyte In Vitro Maturation Outcome. Cells. 2024 Dec;13(24):2024.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies Replication Protein A1 (RPA1) as a critical factor in DNA repair during oogenesis, linking its loss to infertility and chromosome is...
7 months ago

The HELO study evaluates hearing function in virologically suppressed persons living with HIV. Learn how chronic inflammation, vascular factors, and antiretroviral therapy impact auditory decline and why regular audiological monitoring is critical for aging patients.
Today

A population-based study of 20,928 children reveals that small vulnerable newborns face sex-divergent mental capital outcomes at ages 6-7: term SGA girls show higher behavioral difficulties and lower resilience, while preterm non-SGA boys experience increased behavioral problems.
Today

A breakthrough ultrathin multimodal sensor decouples physical hemodynamic monitoring from disposable electrochemical calibration, achieving long-term wearable glucose prediction with 81.36% accuracy and a 9.12% MARD. This offers a robust, drift-free solution for outpatient metabolic surveillance.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today